Literature DB >> 23080082

The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells.

Andrea Balogh1, Eszter Persa, Enikő Noémi Bogdándi, Anett Benedek, Hargita Hegyesi, Géza Sáfrány, Katalin Lumniczky.   

Abstract

OBJECTIVE: Radiotherapy affects antitumor immune responses; therefore, it is important to study radiation effects on various compartments of the immune system. Here we report radiation effects on the homeostasis and function of regulatory T (Treg) cells, which are important in down-regulating antitumor immune responses.
METHODS: C57Bl/6 mice were irradiated with 2 Gy and alterations in splenic lymphocyte fractions analyzed at different intervals.
RESULTS: Total CD4+ numbers showed stronger decrease after irradiation than CD4+Foxp3+ Tregs. Tregs were less prone to radiation-induced apoptosis than CD4+Foxp3- T cells. The ratio of CD4+Foxp3- and CD4+Foxp3+ fractions within the proliferating CD4+ pool progressively changed from 74:26 in control animals to 59:41 eleven days after irradiation, demonstrating a more dynamic increase in the proliferation and regeneration of the Treg pool. The CD4+Foxp3+ fraction expressing cell-surface CTLA4, an antigen associated with Treg cell activation increased from 5.3 % in unirradiated mice to 10.5 % three days after irradiation. The expression of IL-10 mRNA was moderately upregulated, while TGF-β expression was not affected. On the other hand, irradiation reduced Treg capacity to suppress effector T cell proliferation by 2.5-fold.
CONCLUSION: Tregs are more radioresistant, less prone to radiation-induced apoptosis, and have faster repopulation kinetics than CD4+Foxp3- cells, but irradiated Tregs are functionally compromised, having a reduced suppressive capacity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23080082     DOI: 10.1007/s00011-012-0567-y

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  71 in total

1.  Effects of low-dose radiation on the immune system of mice after total-body irradiation.

Authors:  Eniko Noémi Bogdándi; Andrea Balogh; Nikolett Felgyinszki; Tünde Szatmári; Eszter Persa; Guido Hildebrandt; Géza Sáfrány; Katalin Lumniczky
Journal:  Radiat Res       Date:  2010-10       Impact factor: 2.841

2.  Abdominal γ-radiation induces an accumulation of function-impaired regulatory T cells in the small intestine.

Authors:  Fabienne Billiard; Valerie Buard; Marc Benderitter; Christine Linard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-23       Impact factor: 7.038

3.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells.

Authors:  Abdiaziz S Mohamood; Crystal J Trujillo; Dongfeng Zheng; Chunfa Jie; Francisco Martinez Murillo; Jonathan P Schneck; Abdel Rahim A Hamad
Journal:  Int Immunol       Date:  2006-06-12       Impact factor: 4.823

5.  The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma.

Authors:  Wei-Chen Lee; Ting-Jung Wu; Hong-Shiue Chou; Ming-Chin Yu; Pao-Yueh Hsu; Hsiu-Ying Hsu; Chao-Ching Wang
Journal:  Surgery       Date:  2011-10-05       Impact factor: 3.982

Review 6.  Regulatory T cells and cancer.

Authors:  Helen Y Wang; Rong-Fu Wang
Journal:  Curr Opin Immunol       Date:  2007-02-15       Impact factor: 7.486

Review 7.  Regulatory T cells in tumor immunity.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

8.  In vivo studies of the maintenance of peripheral transplant tolerance after cyclosporine. Radiosensitive antigen-specific suppressor cells mediate lasting graft protection against primed effector cells.

Authors:  S J Nisco; R J Hissink; P W Vriens; E G Hoyt; B A Reitz; C Clayberger
Journal:  Transplantation       Date:  1995-05-27       Impact factor: 4.939

9.  Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors.

Authors:  Pankaj Agarwalla; Zachary Barnard; Peter Fecci; Glenn Dranoff; William T Curry
Journal:  J Immunother       Date:  2012-06       Impact factor: 4.456

10.  Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer.

Authors:  Carmen Timke; Hubertus Schmitz Winnenthal; Felix Klug; Falk F F Roeder; Andreas Bonertz; Christoph Reissfelder; Nathalie Rochet; Moritz Koch; Christine Tjaden; Markus W Buechler; Juergen Debus; Jens Werner; Philipp Beckhove; Jürgen Weitz; Peter E Huber
Journal:  BMC Cancer       Date:  2011-04-13       Impact factor: 4.430

View more
  34 in total

1.  Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.

Authors:  Parvathi Ranganathan; Apollinaire Ngankeu; Nina C Zitzer; PierPaolo Leoncini; Xueyan Yu; Lucia Casadei; Kishore Challagundla; Dawn K Reichenbach; Sabrina Garman; Amy S Ruppert; Stefano Volinia; Jessica Hofstetter; Yvonne A Efebera; Steven M Devine; Bruce R Blazar; Muller Fabbri; Ramiro Garzon
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

Review 2.  Radiotherapy and immunotherapy: a beneficial liaison?

Authors:  Ralph R Weichselbaum; Hua Liang; Liufu Deng; Yang-Xin Fu
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

Review 3.  The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.

Authors:  Miles Piper; Adam C Mueller; Sana D Karam
Journal:  Mol Carcinog       Date:  2020-05-04       Impact factor: 4.784

4.  Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.

Authors:  Shelby Lennon; Ayman Oweida; Dallin Milner; Andy V Phan; Shilpa Bhatia; Benjamin Van Court; Laurel Darragh; Adam C Mueller; David Raben; Jorge L Martínez-Torrecuadrada; Todd M Pitts; Hilary Somerset; Kimberly R Jordan; Kirk C Hansen; Jason Williams; Wells A Messersmith; Richard D Schulick; Philip Owens; Karyn A Goodman; Sana D Karam
Journal:  Clin Cancer Res       Date:  2019-04-03       Impact factor: 12.531

Review 5.  Immune recognition of irradiated cancer cells.

Authors:  Erik Wennerberg; Claire Vanpouille-Box; Sophia Bornstein; Takahiro Yamazaki; Sandra Demaria; Lorenzo Galluzzi
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

Review 6.  Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation.

Authors:  Jonathan E Schoenhals; Steven N Seyedin; Clark Anderson; Eric D Brooks; Yun R Li; Ahmed I Younes; Sharareh Niknam; Ailin Li; Hampartsoum B Barsoumian; Maria Angelica Cortez; James W Welsh
Journal:  Transl Lung Cancer Res       Date:  2017-04

Review 7.  Proton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancer.

Authors:  Howard J Lee; Jing Zeng; Ramesh Rengan
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 8.  Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities.

Authors:  Ravi B Patel; Claire C Baniel; Raghava N Sriramaneni; Kristin Bradley; Stephanie Markovina; Zachary S Morris
Journal:  Brachytherapy       Date:  2018-08-02       Impact factor: 2.362

9.  Uncomfortable issues in radiation protection posed by low-dose radiobiology.

Authors:  Carmel Mothersill; Colin Seymour
Journal:  Radiat Environ Biophys       Date:  2013-05-15       Impact factor: 1.925

10.  Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.

Authors:  Ayman J Oweida; Adam C Mueller; Miles Piper; Dallin Milner; Benjamin Van Court; Shilpa Bhatia; Andy Phan; Thomas Bickett; Kimberly Jordan; Theresa Proia; Richard Schulick; Wells A Messersmith; Marco Del Chiaro; Eric Clambey; Michael J Gough; Jason Williams; Kirk Hansen; Karyn Goodman; Sana D Karam
Journal:  Cancer Immunol Immunother       Date:  2020-10-23       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.